Birth Prevalence of Fatty Acid β-Oxidation Disorders in Iberia-Reference-Cited by-同舟云学术

Birth Prevalence of Fatty Acid β-Oxidation Disorders in Iberia

Published:2014 Issue: Volume: Page:89-94
ISSN:2192-8304
Container-title:JIMD Reports
language:
Short-container-title:

Author:

Rocha Hugo,Castiñeiras Daisy,Delgado Carmen,Egea José,Yahyaoui Raquel,González Yolanda,Conde Manuel,González Inmaculada,Rueda Inmaculada,Rello Luis,Vilarinho Laura,Cocho José

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/8904_2014_324

Reference32 articles.

1. Al-Hassnan ZN, Imtiaz F, Al-Amoudi M et al (2010) Medium-chain acyl-CoA dehydrogenase deficiency in Saudi Arabia: incidence, genotype, and preventive implications. J Inherit Metab Dis Suppl 3:S263–S267

2. Arnold GL, Saavedra-Matiz CA, Galvin-Parton PA et al (2010) Lack of genotype–phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State. Mol Genet Metab 99(3):263–268

3. Bartlett K, Eaton S (2004) Mitochondrial beta-oxidation. Eur J Biochem 271(3):462–469

4. Baruteau J, Sachs P, Broue P et al (2013) Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients. J Inherit Metab Dis 36(5):795–813

5. Bennett MJ, Rinaldo P, Wilcken B, Pass KA, Watson MS, Wanders RJA (2012) Newborn screening for metabolic disorders: how are we doing, and where are we going? Clin Chem 58:324–331

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of inherited metabolic diseases in normal newborns and high-risk children: Insights from a 10-year study in Shanghai;Clinica Chimica Acta;2024-05

2. Portuguese Neonatal Screening Program: A Cohort Study of 18 Years Using MS/MS;International Journal of Neonatal Screening;2024-03-20

3. Recomendaciones de manejo de la hiperamonemia en neonatos;Universitas Médica;2023-01-17

4. Medium‐chain Acyl‐COA dehydrogenase deficiency: Pathogenesis, diagnosis, and treatment;Endocrinology, Diabetes & Metabolism;2022-10-27

5. Lymphocyte Medium-Chain Acyl-CoA Dehydrogenase Activity and Its Potential as a Diagnostic Confirmation Tool in Newborn Screening Cases;Journal of Clinical Medicine;2022-05-23